BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute of Biomedical Engineering (BME) - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Institute of Biomedical Engineering (BME)
X-ORIGINAL-URL:https://bme.utoronto.ca
X-WR-CALDESC:Events for Institute of Biomedical Engineering (BME)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230519T130000
DTEND;TZID=America/Toronto:20230519T140000
DTSTAMP:20230509T183039Z
CREATED:20230509T183039Z
LAST-MODIFIED:20230509T183039Z
UID:10000221-1684501200-1684504800@bme.utoronto.ca
SUMMARY:BME Faculty Search Seminar - Nova Pishesha
DESCRIPTION:Exploiting Antigen Presentation Pathways for Precision Immune Engineering \nDr. Nova Pishesha\,\nJunior Fellow\, Society of Fellows at Harvard University\nCurrent treatments for autoimmunity rely on general immunosuppression\, which exposes patients to opportunistic infections. Hence\, immunoregulatory modalities\, which educate the immune system to induce antigen-specific tolerance are desirable. My doctoral research revolved around engineered red blood cells (RBCs) to treat preclinical models of autoimmune diseases by hijacking the tolerogenic RBC clearance pathways. As a postdoctoral fellow\, I worked on an alpaca-derived single domain antibody fragment (nanobody)-based platform. I have engineered these nanobodies to efficiently target antigen presenting cells and transmit either tolerogenic or vaccinal signal to antigen-specific immune cells. I showed that a single dose of a VHH that recognizes major histocompatibility complex class II/MHCII (VHHMHCII)\, conjugated to a myelin peptide and an anti-inflammatory corticosteroid\, i.e. dexamethasone (VHHMHCII-MOG-DEX)\, affords lasting protection in a mouse model of multiple sclerosis (MS). A single dose of VHHMHCII-MOG-DEX also reverses paralyses in mice without compromising the capacity of the immune system to fight pathogens. I further developed this technology for treating type 1 diabetes and as a SARS-CoV-2 vaccine. My independent group will aspire to produce novel treatments for autoimmune and infectious diseases. \nTalk will be in-person and virtual\, see information below.
URL:https://bme.utoronto.ca/event/bme-faculty-search-seminar-nova-pishesha/
LOCATION:MS3153
CATEGORIES:BME Faculty Search
ATTACH;FMTTYPE=image/jpeg:https://bme.utoronto.ca/wp-content/uploads/2023/05/1517545306211.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230503T090000
DTEND;TZID=America/Toronto:20230503T100000
DTSTAMP:20230421T131146Z
CREATED:20230419T152829Z
LAST-MODIFIED:20230421T131146Z
UID:10000215-1683104400-1683108000@bme.utoronto.ca
SUMMARY:BME Faculty Search Seminar - Kibaek Choe
DESCRIPTION:In Vivo Live Cell Imaging by Three-Photon (3P) Microscopy\nDr. Kibaek Choe\,\nPostdoctoral Associate\, Cornell University\nIn vivo confocal and two-photon (2P) microscopies have been a major driving force in deepening our understanding of cell dynamics by enabling the visualization of migration\, distribution\, morphology\, and cell-cell interactions in three dimensions and at subcellular resolution. In this talk\, I will first discuss the key features of confocal and 2P microscopes for in vivo imaging and introduce bio-applications in various mouse organs such as the small intestine\, bone marrow\, and lymph nodes. \nSecondly\, I will talk about 3P microscopy\, which overcomes the depth limitation of confocal and 2P imaging. We applied 3P microscopy to visualize dynamic immune cell behavior in mouse lymph nodes for the first time. We determined safe laser parameters by monitoring immune cell motility in various imaging conditions to prevent photo-damage. Using the safe laser conditions\, we were able to visualize blood vessels through the entire depth of mouse popliteal lymph node in vivo. Additionally\, we could measure the motility of CD4+ and CD8+ T cells through the entire depth of T cell zone in vivo\, allowing us to discover the depth dependence of CD4+ T cell motility in the T cell zone during lipopolysaccharide-induced inflammation. \nThus\, in vivo 3P microscopy has the potential to uncover previously unknown cellular dynamics in deeper regions of many other organs beyond the depth limit of conventional confocal and 2P microscopies. \nTalk will be in-person and virtual\, see information below.
URL:https://bme.utoronto.ca/event/bme-faculty-search-seminar-kibaek-choe/
LOCATION:MS3153
CATEGORIES:BME Faculty Search
ATTACH;FMTTYPE=image/jpeg:https://bme.utoronto.ca/wp-content/uploads/2023/04/Kibaek-Choe.v4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220913T120000
DTEND;TZID=America/Toronto:20220913T130000
DTSTAMP:20220901T132242Z
CREATED:20220606T143441Z
LAST-MODIFIED:20220901T132242Z
UID:10000030-1663070400-1663074000@bme.utoronto.ca
SUMMARY:Invited Academic Seminar Series – Ehsan Hoque- Embedding human values in digital medicine (Hybrid Delivery)
DESCRIPTION:Speaker\nEhsan Hoque\nAssociate Professor\nComputer Science\nUniversity of Rochester \n\nAbstract\nMany argue that making interoperability\, federal incentives\, barcoding\, and deep learning is the core of revolutionizing healthcare information technology. It is. But it is also about developing technologies that align with our values and integrate effortlessly with our lifestyles and healthcare workflow while improving access and equity. \nIn this talk\, I will highlight the following projects and their design principles\, technical contributions\, and a roadmap to integrating them within the existing healthcare workflow. \n1)      How to develop an automated screening and tracking of Parkinson’s disease—the fastest-growing neurological disability —through a series of tasks on a webcam anytime\, anywhere? \n2)      How can AI assist doctors in improving empathy and listening skills as they help terminally ill patients make critical decisions? \n3)      How can virtual avatars with standardized\, repeatable\, and objective feedback improve the social skills of individuals who struggle with socio-emotional communication\, such as those with Autism? \nAlong with technical contributions\, I will reflect on the journey of how a trained computer scientist like myself could get into healthcare research driven by personal circumstances and enabled by excellent collaborators. \nBio: Ehsan Hoque is an associate professor of computer science at the University of Rochester\, where he co-leads the Rochester Human-Computer Interaction (ROC HCI) Group. From 2018-2019\, he was also the Interim Director of the Goergen Institute for Data Science. Ehsan earned his Ph.D. from MIT in 2013\, where the MIT Museum highlighted his dissertation—the development of an intelligent agent to improve human ability — as one of MIT’s most unconventional inventions. Building on the work/patent\, Microsoft released “Speaker Coach” available in PowerPoint. Ehsan is best known for introducing and extensively validating the idea of using AI to train and enhance elements of basic human ability. \nEhsan and his students’ work has been recognized by NSF CAREER Award\, MIT TR35\, Young Investigator Award by the US Army Research Office (ARO). In 2017\, Science News named him one of the 10 scientists to watch\, and in 2020\, the National Academy of Medicine recognized him as one of the emerging leaders in health and medicine. Ehsan is blessed to be the primary caregiver of his younger brother\, 22\, who is nonverbal and diagnosed with Autism and down syndrome. \n\nHost\nLueder Kahrs
URL:https://bme.utoronto.ca/event/invited-academic-seminar-series-ehsan-hoque/
LOCATION:MS3153
ATTACH;FMTTYPE=image/jpeg:https://bme.utoronto.ca/wp-content/uploads/2022/06/Hoque-Ehsan-Nov-2021-LR.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220614T130000
DTEND;TZID=America/Toronto:20220614T140000
DTSTAMP:20220609T150017Z
CREATED:20220609T144415Z
LAST-MODIFIED:20220609T150017Z
UID:10000046-1655211600-1655215200@bme.utoronto.ca
SUMMARY:Faculty Search Candidate Talk
DESCRIPTION:This event will be in person only.
URL:https://bme.utoronto.ca/event/faculty-search-talk-2-2022/
LOCATION:MS3153
CATEGORIES:BME Faculty Search
END:VEVENT
END:VCALENDAR